BELRAPZO

NDC 42367-521 · Eagle Pharmaceuticals, Inc

Generic namebendamustine hydrochloride

Dosage formINJECTION

RouteINTRAVENOUS

Active ingredient(s)BENDAMUSTINE HYDROCHLORIDE

Strength100 mg/4mL

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryNDA

Packages

42367-521-25 — 1 VIAL, MULTI-DOSE in 1 CARTON (42367-521-25) / 4 mL in 1 VIAL, MULTI-DOSE

Billed under HCPCS

J9036 — Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg Medicare Part B payment limit (ASP + 6%): $11.60

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

10019-079 — bendamustine hydrochloride, 16729-250 — bendamustine hydrochloride, 16729-251 — bendamustine hydrochloride, 24338-270 — BENDAMUSTINE HYDROCHLORIDE, 55150-391 — BENDAMUSTINE HYDROCHLORIDE, 55150-392 — BENDAMUSTINE HYDROCHLORIDE, 60505-6228 — Bendamustine Hydrochloride, 63459-348 — bendamustine hydrochloride, 63459-390 — Bendamustine Hydrochloride, 63459-391 — Bendamustine Hydrochloride, 68001-572 — bendamustine hydrochloride, 71225-120 — BENDAMUSTINE HYDROCHLORIDE, 71288-102 — bendamustine HCl, 71288-103 — Bendamustine HCl, 83831-183 — bendamustine hydrochloride

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.